|
Mutation Information
|
Mutation Site
|
M41L |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Combined Mutation
|
rt.L210W+rt.T215Y+rt.M41L;rt.T215F+rt.M41L;rt.T215Y+rt.M41L |
|
Viral Reference
|
K03455.1
|
|
Relevant Drug
|
NRTIs |
|
Country
|
Panama |
Literature Information
|
PubMed PMID
|
27119150
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2016 |
|
Journal
|
PloS one |
|
Title
|
HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes. |
|
Author
|
Mendoza Y,Castillo Mewa J,Martínez AA,Zaldívar Y,Sosa N,Arteaga G,Armién B,Bautista CT,García-Morales C,Tapia-Trejo D,Ávila-Ríos S,Reyes-Terán G,Bello G,Pascale JM |
|
Evidence
|
The nucleoside reverse transcriptase inhibitor (NRTI) mutation M184V was more frequent in ARV drug-experienced individuals, while T215YFrev and M41L were more frequent in ARV drug-naive subjects.
|
|
|
HIV Mutation Detail Information